News

Booking Holdings (BKNG) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Cleveland-Cliffs (CLF) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the

NetApp (NTAP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Over

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck.

How do you find the

Merit Medical Systems MMSI announced that it has signed a definitive agreement to acquire the C2 CryoBalloon technology from Pentax of America, a subsidiary of PENTAX Medical, Inc. The innovative

RTX Corporation RTX is scheduled to release third-quarter 2025 results on Oct. 21, before market open. The company delivered an earnings surprise of 7.59% in the last reported quarter. Let’s discuss

The Trade Desk TTD boasts a strong balance sheet with a cash position (cash, cash equivalents and short-term investments) of $1.7 billion at the end of the second quarter. It reported free cash flow

Pharma-giant Johnson & Johnson (JNJ) recently reported better-than-expected third-quarter 2025 results. The drugmaker continued its streak of earnings beat and also beat on sales estimates. The

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

We know

Quarterly financial reports play a vital role on Wall Street, as they help investors see how a company has performed and what might be coming down the road in the near-term. And out of all of the

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

Life and

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

The

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that

Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and

Novartis NVS recently announced positive final results from the late-stage, APPLAUSE-IgAN, study on Fabhalta (iptacopan) in adults living with IgA nephropathy (IgAN), a progressive autoimmune kidney

Thermo Fisher Scientific Inc. TMO is slated to release third-quarter 2025 results on Oct. 22, before market open.

In the last reported quarter, earnings of $5.36 per share beat the Zacks Consensus

For investors seeking momentum, First Trust Institutional Preferred Securities and Income ETF (FPEI) is probably on the radar now. The fund just hit a 52-week high and is up 9.5% from its 52-week

Boston Scientific BSX is slated to report third-quarter 2025 results on Oct. 22, before market open.

The renowned medical device manufacturer posted earnings per share (EPS) of 75 cents in the last